Incidental detection of the small renal mass (SRM) is increasingly common in the elderly population. 1 Hock L.M. Lynch J. Balaji K.C. Increasing incidence of all stages of kidney cancer in the last 2 decades in the United States: an analysis of surveillance, epidemiology and end results program data. J Urol. 2002; 167: 57-60 Abstract Full Text Full Text PDF PubMed Scopus (339) Google Scholar Although most of these lesions are clinical stage I renal cell carcinomas (RCC), a growing body of published data exists demonstrating that the natural history of untreated localized SRMs is rather indolent in the short to intermediate term. 2 Jewett M.A. Zuniga A. Renal tumor natural history: the rationale and role for active surveillance. Urol Clin North Am. 2008; 35: 627-634 Abstract Full Text Full Text PDF PubMed Scopus (59) Google Scholar Multiple observational series note that the rate of progression to metastatic disease is 1%-2% during a median time of 30 months. 3 Chawla S. Crispen P. Hanlon A. et al. The natural history of enhancing renal masses: a meta-analysis and review of the world literature. J Urol. 2006; 175: 425-431 Abstract Full Text Full Text PDF PubMed Scopus (592) Google Scholar Moreover, of those lesions under active surveillance reported in the published data that do metastasize, the average time from diagnosis to metastatic RCC (mRCC) was in excess of 65 months. 4 Kunkle D.A. Chen D.Y.T. Greenberg R.E. et al. Metastatic progression of enhancing renal masses under active surveillance is associated with rapid interval growth of the primary tumor. J Urol. 2008; 179: S375 Abstract Full Text PDF Google Scholar The possibility of overtreatment of the SRM in the elderly patients poses a clinical dilemma, namely whether excision, ablation, or observation is best in this population. 5 Kunkle D.A. Egleston B.L. Uzzo R.G. Excise, ablate or observe: the small renal mass dilemma—a meta-analysis and review. J Urol. 2008; 179 (discussion:1233-1234): 1227-1233 Abstract Full Text Full Text PDF PubMed Scopus (416) Google Scholar Laparoscopic Partial Nephrectomy in OctogenariansUrologyVol. 74Issue 5PreviewTo assess the safety and technical feasibility of laparoscopic partial nephrectomy in patients aged ≥80 years at our institution to determine whether this treatment modality may be justifiable in select octogenarians. As the US population ages, an increasing number of elderly patients with renal masses are considered for partial nephrectomy. We present our experience with laparoscopic partial nephrectomy in octogenarians to determine the safety and technical feasibility of this procedure in an elderly population. Full-Text PDF Editorial CommentUrologyVol. 74Issue 5PreviewThe current manuscript demonstrates that laparoscopic partial nephrectomy can be performed safely in octogenarians. However, it must be noted that the authors represent extremely talented and experienced laparoscopic surgeons and are considered pioneers in the field of laparoscopic renal surgery. Although it is doubtful that these findings can be generalized to all practicing Urologists, the manuscript details several critical concepts in the contemporary management of renal tumors, including proper patient selection, preservation of renal function, and limiting treatment-associated morbidity. Full-Text PDF ReplyUrologyVol. 74Issue 5PreviewAlthough fundamental, the question, “Should we excise SRMs in the elderly?” is not the topic of our retrospective review. We agree whole-heartedly that in the elderly and the infirm population, the risk of competing comorbidities must be weighed against the admittedly limited oncological risk of the small renal mass (SRM).1 The goal of our manuscript is less lofty; namely, to evaluate the technical feasibility, safety, and outcomes of LPN surgery in an elderly subgroup. All patients underwent LPN for an “enhancing” SRM, on the basis of CT imaging performed at our institution. Full-Text PDF ReplyUrologyVol. 74Issue 5PreviewAlthough fundamental, the question, ‘Should we excise SRMs in the elderly?’ is not the topic of our retrospective review. We agree whole-heartedly that, in the elderly and the infirm, the risk of competing comorbidities must be weighed against the admittedly limited oncological risk of the small renal mass (SRM).1 The goal of our manuscript is less lofty, namely, to evaluate the technical feasibility, safety, and outcomes of LPN surgery in the elderly. All patients underwent LPN for an “enhancing” SRM, based on CT imaging performed at our institution. Full-Text PDF